We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
Protein-arginine deiminase type-4 (PADI4) antibody
HL-60 PAD
Peptidylarginine deiminase IV
Protein-arginine deiminase type IV
Gene name : PADI4, PADI5, PDI5
Peptidylarginine deiminase IV
Protein-arginine deiminase type IV
Gene name : PADI4, PADI5, PDI5
As low as
$306.10
In stock
Ref
00013411
PADI4 is the enzyme that catalyze the citrullination or the deimination of arginine on proteins like Histone H3.
| ID Covalab | pab0199 |
|---|---|
| Product type | Primary antibodies |
| Clonality | Polyclonal antibody |
| Raised in | Rabbit |
| Immunogen | Synthetic peptide from N terminal part of human PADI4 protein |
| Activity cross reaction | Reacts with PADI4 from human, mouse and rat. No cross reaction with the other isoforms. |
| Species | Hu, Ms, Rat |
| Labelling | None |
| Form | Antiserum |
| Preservative | None |
| Storage instructions | Lyophilized powder stable for a minimum of 2 years at -20°C. Store reconstituted antibodies at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt. |
| Target | Protein-arginine deiminase type-4 |
| Antibody / Antigen | pep0199 |
| Uniprot ID | Q9UM07 |
| Gene ID | 23569 |
| Applications | ELISA, ICC, IF, IHC, IP, WB |
| Working dilutions | Optimal dilution should be determined by the end user. The following are guidelines only : ELISA (1:1000 - 1:5000) ICC (1:50 - 1:100) IP (1:20 - 1:100) WB (1:200 - 1:2000) |
| Publication | * Durrant LG et al - US Patent App. 14/614,964, 2019 * Durrant LG et al. Anti-tumour response to modified self-epitopes. US Patent App. 16/007,944, 2018 |
Write Your Own Review